integrated genomic analysis human glioblastoma multiforme 
glioblastoma multiforme gbm common lethal type brain cancer identify genetic alterations gbms sequenced protein coding genes determined presence amplifications deletions using high density oligonucleotide arrays performed gene expression analyses using next generation sequencing technologies human tumor samples comprehensive analysis led discovery variety genes known altered gbms notably found recurrent mutations active site isocitrate dehydrogenase idh1 % gbm patients mutations idh1 occurred large fraction young patients patients secondary gbms associated increase overall survival studies demonstrate value unbiased genomic analyses characterization human brain cancer identify potentially useful genetic alteration classification targeted therapy gbms 
